We pulled data from our naturalistic psilocybin study (still the largest one in the world) with people who planned to
While clinical trials have shown promise in treating depression, anxiety, and substance use disorders, little is known about how psilocybin
Psychedelics may act as catalysts for nervous system regulation and embodied memory processing, bringing suppressed trauma to the surface.
Can a single psychedelic experience shift your entire worldview? It’s a provocative question, and one that’s sparked widespread interest as
Recent research suggests that psilocybin shows promise in treating addiction. Studies have demonstrated its potential efficacy in treating tobacco and
You can access a list of currently recruiting U.S. clinical trials on psilocybin through ClinicalTrials.gov.
In our recent large-scale study of psilocybin magic mushrooms, 4.6% of users reported using psilocybin while on an antidepressant.
Results from our recent large-scale study with John Hopkins University found significantly decreased depression persisting for months following psilocybin ingestion.
From our naturalistic psilocybin study, the average initial dose of dried psilocybin mushrooms was 3.1 grams.
Psilocybin has been used safely for patients with OCD and was associated with acute reductions in core OCD symptoms in
Join our email list and get immediate access to part one of our psilocybin guide. You’ll also get the latest in how we’re bridging the gap between science and soul: psychedelic research updates, real-world findings, community-driven education, personal stories and expert insights on natural medicine.
Advancing Real-World Psychedelic Research and Science-Backed Education
Unlimited Sciences is provided a nonprofit status by fiscal sponsorship through Realm of Caring Foundation.
Federal EIN: 46-3371348.
© 2025 Unlimited Sciences. All Rights Reserved.
Designed by Gloss
